Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12444789 | 0.93 | CA1 (0.38) | CA1CA2CA4KMT2A | |
| SCHEMBL424899 | 0.86 | — | — | |
| SCHEMBL8898871 | 0.77 | TRIM24 (0.38) | CA1CA2CA4KMT2A | |
| SCHEMBL23048936 | 0.75 | CA1 (0.31) | CA1CA2CA4KMT2A | |
| SCHEMBL4374227 | 0.73 | MT-CO2 (0.46) | CA1CA2CA4KMT2A | |
| SCHEMBL10719777 | 0.73 | MT-CO2 (0.46) | CA1CA2CA4KMT2A | |
| SCHEMBL3277309 | 0.73 | CA1 (0.43) | CA1CA2CA4KMT2A | |
| SCHEMBL6535460 | 0.73 | MT-CO2 (0.46) | CA1CA2CA4KMT2A | |
| SCHEMBL431589 | 0.72 | — | — | |
| SCHEMBL20663434 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9246187-B2 | Non-aqueous electrolyte for lithium-ion battery | UCHICAGO ARGONNE, LLC (US) | 2016-01-26 | — | — | US | disclosed |
| US-9218915-B2 | Non-aqueous electrolyte for lithium-ion battery | UCHICAGO ARGONNE, LLC (US) | 2015-12-22 | — | — | US | disclosed |
| US-8952179-B2 | Synthesis process, and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy} benzamide hydrochloride and pharmaceutical compositions containing it | LES LABORATORIES SERVIER (FR) | 2015-02-10 | — | — | US | disclosed |
| US-20140272607-A1 | NON-AQUEOUS ELECTROLYTE FOR LITHIUM-ION BATTERY | UCHICAGO ARGONNE LLC (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140186721-A1 | NON-AQUEOUS ELECTROLYTE FOR LITHIUM-ION BATTERY | UCHICAGO ARGONNE, LLC (US) | 2014-07-03 | — | — | US | disclosed |
| US-20140155453-A1 | SYNTHESIS PROCESS, AND CRYSTALLINE FORM OF 4-{3[CIS-HEXAHYDROCYCLOPENT A[CjPYRROL-2( 1 H)-YLjPROPOXYj BENZAMI DE HYDROCHLORI DE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | LES LABORATOIRES SERVIER (FR) | 2014-06-05 | — | — | US | disclosed |
| US-8664408-B2 | Synthesis process, and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]proxy}benzamide hydrochloride and pharmaceutical compositions containing it | LES LABORATOIRES SERVIER (FR) | 2014-03-04 | — | — | US | disclosed |
| US-20120316214-A1 | SYNTHESIS PROCESS, AND CRYSTALLINE FORM OF 4-BENZAMIDE HYDROCHLORIDE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | LES LABORATOIRES SERVIER (FR) | 2012-12-13 | — | — | US | disclosed |
| US-20120088160-A1 | NON-AQUEOUS ELECTROLYTE FOR LITHIUM-ION BATTERY | UCHICAGO ARGONNE, LLC | 2012-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088160-A1 | NON-AQUEOUS ELECTROLYTE FOR LITHIUM-ION BATTERY | VDAC1, VDAC2, CA2 | CA1 11/4885CA2 3/4885CA4 45/4885 |
| US-20140155453-A1 | SYNTHESIS PROCESS, AND CRYSTALLINE FORM OF 4-{3[CIS-HEXAHYDROCYCLOPENT A[CjPYRROL-2( 1 H)-YLjPROPOXYj BENZAMI DE HYDROCHLORI DE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | HRH2, HRH1, HRH4 | CA1 151/4885CA2 43/4885CA4 156/4885 |
| US-20120316214-A1 | SYNTHESIS PROCESS, AND CRYSTALLINE FORM OF 4-BENZAMIDE HYDROCHLORIDE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | HRH4, HRH2, HRH1 | CA1 788/4885CA2 78/4885CA4 32/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.